You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 30, 2025

Drug Price Trends for NDC 50991-0740


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 50991-0740

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 50991-0740

Understanding the NDC Code

The National Drug Code (NDC) is a unique 11-digit code assigned to each medication under Section 510 of the US Federal Food, Drug, and Cosmetic Act. The NDC 50991-0740 identifies a specific drug product, including its name, strength, and dosage form[2][5].

Drug Identification

To analyze the market and price projections for NDC 50991-0740, it is crucial to identify the drug associated with this code. However, the provided sources do not specify the exact drug corresponding to this NDC. Typically, this information can be found through databases such as the CDC's vaccine code sets or the Medicaid Drug Rebate program files[2][4].

Market Trends in Pharmaceutical Pricing

Overall Pharmaceutical Market

The pharmaceutical market is subject to various trends and factors that influence pricing. For instance, the Vizient Pharmacy Market Outlook for 2024-2025 projects a 0.00% overall drug price inflation rate, indicating a stable pricing environment for many drugs. However, this does not account for individual drug variations or new market entrants[3].

Gene Therapy and Advanced Treatments

The increasing development and approval of gene therapies and other advanced treatments are driving up costs in the healthcare sector. While these therapies are not directly related to the specific NDC in question, they highlight the broader trend of escalating costs for innovative treatments[3].

Pricing Mechanisms

National Average Drug Acquisition Cost (NADAC)

The NADAC is a critical metric for determining the average cost at which pharmacies acquire drugs. It is calculated based on surveys of pharmacy acquisition costs and can be adjusted for various factors such as changes in published pricing or inquiries to the help desk. Understanding the NADAC for a specific drug helps in projecting its market price[2].

340B Ceiling Price

For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is an important pricing benchmark. This price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure and then adjusting for package size and case pack size. This mechanism ensures that covered entities pay no more than the statutory ceiling price[5].

Price Projections

Data Collection and Analysis

To project the price of a drug with NDC 50991-0740, one would typically analyze historical pricing data, including NADAC and 340B ceiling prices, as well as any recent changes in the market or regulatory environment. This involves reviewing pharmacy survey data, manufacturer pricing, and any adjustments made to the NADAC or 340B ceiling prices[2][5].

Market Factors

Several factors can influence price projections:

  • Regulatory Changes: Changes in FDA approvals, drug classifications, or rebate program eligibility can impact pricing.
  • Market Competition: The presence of generic or brand competitors can affect the pricing strategy.
  • Economic Conditions: Overall economic trends, including inflation and healthcare spending, can influence drug prices.
  • Innovative Treatments: The introduction of new, expensive treatments can shift market dynamics and pricing strategies[3].

Key Takeaways

  • Identify the Drug: Determine the specific drug associated with NDC 50991-0740 to understand its market context.
  • Use NADAC and 340B Data: Analyze historical NADAC and 340B ceiling prices to project future pricing trends.
  • Consider Market Trends: Factor in broader pharmaceutical market trends, including the impact of advanced treatments and regulatory changes.
  • Monitor Regulatory Updates: Keep abreast of any changes in FDA approvals, drug classifications, or rebate program eligibility.

FAQs

Q1: What is the National Drug Code (NDC)? The NDC is an 11-digit code that identifies a drug product, including its name, strength, and dosage form, as maintained by the FDA.

Q2: How is the NADAC calculated? The NADAC is calculated using information from pharmacy surveys, and it can be adjusted based on changes in published pricing or inquiries to the help desk[2].

Q3: What is the 340B ceiling price? The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusting for package size and case pack size[5].

Q4: How do market trends affect drug pricing? Market trends, such as the introduction of new treatments and changes in regulatory policies, can significantly impact drug pricing. For example, the rise of gene therapies is driving up healthcare costs[3].

Q5: Where can I find historical pricing data for a specific NDC? Historical pricing data can be found through resources such as the Medicaid Drug Rebate program files, NADAC data files, and 340B pricing databases[2][5].

Sources

  1. Medicaid.gov: For State Medicaid Directors - State Releases[1].
  2. Medicaid.gov: National Average Drug Acquisition Cost (NADAC) Data Field Definitions[2].
  3. Vizient Inc.: Pharmacy Market Outlook Summer 2024[3].
  4. CDC: Code Sets - NDC - Vaccines[4].
  5. HRSA: NDC Product Details - 340B OPAIS[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.